Bioprocess Bags Market Introduction and Overview
According to SPER Market Research, the Global Bioprocess Bags Market is estimated to reach USD 19.76 billion by 2034 with a CAGR of 16.61%.
The report includes an in-depth analysis of the Global Bioprocess Bags Market, including market size and trends, product mix, Applications, and supplier analysis. The global bioprocess bags market was valued at USD 4.25 billion in 2024 and is predicted to increase at a CAGR of 16.61% between 2025 and 2034. Several reasons are driving the market, including increased demand for biopharmaceuticals such as monoclonal antibodies and vaccines, advances in bioprocess technology such as single-use systems and disposable bioprocess bags, and the growing acceptance of modular manufacturing. Furthermore, the growing need for customized medicine is driving the development of new biologics and other complex therapies, which necessitate specific production methods that can be aided by bioprocess bags.
By Type Insights: The 2D bioprocess bags held the largest market share in 2024 due to the rising demand for biopharmaceuticals and cell therapies. As chronic diseases like cancer, diabetes, and autoimmune disorders increase, there is a need for innovative treatments. Biopharmaceuticals provide a solution, and 2D bioprocess bags can make manufacturing more efficient and cost-effective. This market is also influenced by advances in bag design and materials, focusing on strength, durability, and customization for various applications.
By Workflow Insights: The upstream process segment had the largest market share in 2024. Bioprocessing bags are commonly used for cell culture, media preparation, and fermentation. They create a sterile environment for cell growth and are designed to enhance productivity. Available in different sizes, they offer flexibility in processes. The demand for these bags is rising due to the need for biopharmaceuticals, the move towards single-use technologies, and their cost and efficiency benefits.
By End User Insights: The pharmaceutical and biopharmaceutical companies segment held the highest market share in 2024. Key market activities like expansion, new product launch, mergers and acquisitions, and collaboration create profitable opportunities. For example, in February 2021, Saint-Gobain launched efficient cell culture bags for T-cell expansion, providing a sterile environment for T-cell growth used in cell-based therapies.
By Regional Insights: North America bioprocess bags market dominated the global market with a share in 2024. The growing demand for biopharmaceuticals is expected to boost the bioprocess bags market in the region. Factors contributing to this growth include the rising use of single-use bioprocessing technologies and a focus on lowering costs tied to advanced therapies. Moreover, the presence of major biopharmaceutical companies and contract manufacturing organizations (CMOs) in North America increases the need for high-quality bioprocess bags.
Market Competitive Landscape:
The Bioprocess Bags market is extremely competitive, with both established and rising competitors. A significant number of players are rapidly expanding geographically, collaborating strategically, and forming alliances through mergers and acquisitions in growing and economically beneficial locations. Key market players are Thermo Fisher Scientific Inc, Sartorius AG, Danaher Corporation, Merck KGaA, Saint-Gobain, Corning Incorporated, Entegris, Meissner Filtration Products, Inc, PROAnalytics, LLC, CellBios Healthcare & Lifesciences Pvt Ltd.
Recent Developments:
- March 5, 2024: The Sartorius Group, a worldwide supplier of pharmaceutical and laboratory equipment, focused on bioprocess solutions, created the Sartorius Flexboy single-use bag, a 2D bag option, available in chamber volumes from 5 ml to 50 L. This flexible series of Flexboy Pre-Designed Solutions (PDS) enables the handling of all biopharmaceutical fluids, such as sterile filtration, transfer, and storage. The various configurations are made for easy integration into different process steps.
- In April 2022, Thermo Fisher Scientific, Inc. announced a new manufacturing facility in Ogden, Utah, to produce materials and technology for new vaccines and therapies. The USD 44 million facility will help meet the rising demand for single-use technology.
- Thermo Fisher Scientific Inc will open its largest single-use technology production facility in Greater Nashville in August 2022, with a USD 150 million investment. The Lebanon, Tennessee factory is the largest manufacturing facility in the company's biologics production network.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Type, By Workflow, By End User. |
| Regions covere | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa. |
| Companies Covered | Thermo Fisher Scientific Inc, Sartorius AG, Danaher Corporation, Merck KGaA, Saint-Gobain, Corning Incorporated, Entegris, Meissner Filtration Products, Inc, PROAnalytics, LLC, CellBios Healthcare & Lifesciences Pvt Ltd. |
Key Topics Covered in the Report:
- Global Bioprocess Bags Market Size (FY’2021-FY’2034)
- Overview of Global Bioprocess Bags Market
- Segmentation of Global Bioprocess Bags Market By Type (2D Bioprocess Bags, 3D Bioprocess Bags, Other Bags & Accessories)
- Segmentation of Global Bioprocess Bags Market By Workflow (Upstream Process, Downstream Process, Process Development)
- Segmentation of Global Bioprocess Bags Market By End User (Pharmaceutical & Biopharmaceutical Companies, CMOs & CROs, Academic & Research Institutes)
- Statistical Snap of Global Bioprocess Bags Market
- Expansion Analysis of Global Bioprocess Bags Market
- Problems and Obstacles in Global Bioprocess Bags Market
- Competitive Landscape in the Global Bioprocess Bags Market
- Details on Current Investment in Global Bioprocess Bags Market
- Competitive Analysis of Global Bioprocess Bags Market
- Prominent Players in the Global Bioprocess Bags Market
- SWOT Analysis of Global Bioprocess Bags Market
- Globa Bioprocess Bags Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Bioprocess Bags Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Bioprocess Bags Market
7. Global Bioprocess Bags Market, By Type (USD Million) 2021-2034
7.1. 2D Bioprocess Bags
7.2. 3D Bioprocess Bags
7.3. Other Bags & Accessories
8. Global Bioprocess Bags Market, By Workflow (USD Million) 2021-2034
8.1. Upstream Process
8.2. Downstream Process
8.3. Process Development
9. Global Bioprocess Bags Market, By End User (USD Million) 2021-2034
9.1. Pharmaceutical & Biopharmaceutical Companies
9.2. CMOs & CROs
9.3. Academic & Research Institutes
10. Global Bioprocess Bags Market, (USD Million) 2021-2034
10.1. Global Bioprocess Bags Market Size and Market Share
11. Global Bioprocess Bags Market, By Region, (USD Million) 2021-2034
11.1. Asia-Pacific
11.1.1. Australia
11.1.2. China
11.1.3. India
11.1.4. Japan
11.1.5. South Korea
11.1.6. Rest of Asia-Pacific
11.2. Europe
11.2.1. France
11.2.2. Germany
11.2.3. Italy
11.2.4. Spain
11.2.5. United Kingdom
11.2.6. Rest of Europe
11.3. Middle East and Africa
11.3.1. Kingdom of Saudi Arabia
11.3.2. United Arab Emirates
11.3.3. Qatar
11.3.4. South Africa
11.3.5. Egypt
11.3.6. Morocco
11.3.7. Nigeria
11.3.8. Rest of Middle-East and Africa
11.4. North America
11.4.1. Canada
11.4.2. Mexico
11.4.3. United States
11.5. Latin America
11.5.1. Argentina
11.5.2. Brazil
11.5.3. Rest of Latin America
12. Company Profile
12.1. Thermo Fisher Scientific Inc
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. Sartorius AG
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. Danaher Corporation
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. Merck KGaA
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. Saint-Gobain
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. Corning Incorporated
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. Entegris
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. Meissner Filtration Products, Inc
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. PROAnalytics, LLC
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments
12.10. CellBios Healthcare and Lifesciences Pvt Ltd
12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Product summary
12.10.4. Recent developments
12.11. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
